NCT00974441View on ClinicalTrials.gov

Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Healthy
Interventions
DRUG

Divalproex Sodium

500 mg Extended Release Tablet

DRUG

Depakote®

500 mg Extended Release Tablet

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00974441 - Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter